Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Cardamonin suppresses glycolysis and induces oxidative stress by inhibiting PI3K/AKT/mTOR pathway in bladder cancer cells

Ping Li¹, Chaopeng Tang¹, Dian Fu¹, Xiaofeng Xu¹, Jingping Ge¹, Ruipeng Jia²

¹Department of Urology, Jinling Hospital, Jinling School of Clinical Medicine, Nanjing Medical University, 210001, China; ²Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province 210006, China.

For correspondence:- Ruipeng Jia Email: Jiaruipeng_666@163.com Tel:+862552271061

Accepted: 24 July 2023 Published: 30 August 2023

Citation: Li P, Tang C, Fu D, Xu X, Ge J, Jia R. Cardamonin suppresses glycolysis and induces oxidative stress by inhibiting PI3K/AKT/mTOR pathway in bladder cancer cells. Trop J Pharm Res 2023; 22(8):1541-1546 doi: 10.4314/tjpr.v22i8.2

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To evaluate the effect and underlying mechanisms of action of cardamine on the progression of bladder cancer (BC).

Methods: Human bladder epithelium immortalized cell line (SV-HUC-1) and human bladder cancer (BC) cell lines (T24 and UM-UC-3) were used in this investigation. They were treated with cardamine at concentrations of 0, 15, 30, 60 or 120 μmol/L. Cell viability was determined using cell counting kit 8 (CCK-8) assay while 5-ethynyl-2'-deoxyuridine (Edu) assay was used to assess cell proliferation. Cell apoptosis as well as reactive oxygen species (ROS) accumulation were determined by flow cytometry whereas glucose uptake, adenosine triphosphate (ATP) level and lactate production were determined using their respective assay kits. Furthermore, the expression levels of nuclear factor level (erythroid-derived 2)-like 2 (Nrf2), NAD(P)H, quinone oxidoreductase 1 (NQO1), protein kinase B (AKT), phosphorylated-AKT (p-AKT), phosphatidylinositol 3-kinase (PI3K), p-PI3K, mechanistic target of rapamycin kinase (mTOR) and p-mTOR were evaluated by western blot analysis.

Results: Cardamine significantly reduced cell viability and inhibited cell proliferation in BC cells in a dose-dependent manner, but did not affect human normal cells. In addition, treatment with the compound induced apoptosis in BC cells; the higher the concentration, the higher the apoptosis level. Besides, cardamine administration suppressed aerobic glycolysis, and decreased the nuclear factor level (Nrf2) level, thereby increasing ROS production in a concentration-dependent manner. Furthermore, it blocked the activation of PI3K/AKT/mTOR signal cascade.

Conclusion: Cardamine inhibits glycolysis and PI3K/AKT/mTOR pathway, and also promotes apoptosis as well as oxidative stress in BC cells. Thus, the compound is a potential therapeutic reagent for BC.

Keywords: Bladder cancer, Cardamine, Glycolysis, Reactive oxygen species, PI3K/AKT/mTOR pathway